It is quite ridiculous ..that this can take so many years to approve.. Malaria cases have grown since Ebola epidemic... if the malaria was in the west they would of approved this 5 years ago
way too long .. 20 years in development thousands in trials........ get this approved this year ..
will they add imet to the mix?
So what they waiting on to take this to the next step the clinic? hopefully we get good news about this soon?
Gambia: Journalists, Scientists Discuss Experimental RTS's Malaria Vaccine
Gambia: Two Supreme Court Judges Removed - Report
Gambia: British National Arraigned for Libel
Gambia: Former PS for Petroleum Charged
Gambia: UDP National Treasurer Appeal Briefs Set for Adoption Today
Africa: Call for Boosted Aids Treatment Amid Threat of Viral Resurgence
Sierra Leone: A Year With Ebola - the Grievous Experience of Health Care Workers
Africa: UNAIDS and Lancet Commission Call for Urgent Action On Aids Response
Liberia: Ganta Ebola Monument Center Dedicated
Nigeria: Malaria - U.S. Donates Insecticide-Treated Nets to Ebonyi, Cross River
Nigeria: Zamfara to Destroy 2.6 Million Mosquito Net Jackets Over Chemical Infection
Africa: Voices At the Partnership Forum 2015
Guinea: Malaria Deaths in Guinea Likely to Exceed Ebola Toll As Patients Shun Clinics
Nigeria: Obama to Host Buhari, High-Level Consultations Planned
Nigeria: Nigerian President Buhari to Recover Stolen Money
Nigeria: Nigerian President Buhari Invited to White House for Consultations
Cote d'Ivoire: New Research On Religious Radicalism in Côte d'Ivoire Informs Policy
By Momodou Faal
Italy — Sixteen African journalists, scientists and communication experts from Europe, Africa and USA are meeting at Bellagio in Italy to develop a strategic media framework for advocacy on the experimental RTS's malaria vaccine ahead of a policy recommendation by the World Health Organisation and other drug regulatory agencies.
The meeting is aimed at strengthening advocacy on the malaria elimination agenda to consolidate the gains made in the fight against the disease, especially in developing countries and position the continent of Africa for the malaria vaccine.
It is organised by the African Media and Malaria Research Network (AMMREN) in collaboration with the Rockefeller Foundation.
The RTS's candidate vaccine is the most clinically advanced experimental vaccine to date and it is on trial in Africa involving seven African countries - Ghana, Burkina Faso, Gabon, Kenya, Malawi, Mozambique and Tanzania. Some 15,459 infants and young children have taken part in the trial.
Method for identification of sensitivity of a patient to telomerase inhibition therapy
The invention provides methods for determining the susceptibility of cancer patients to developing adverse reactions if treated with a telomerase inhibitor drug by measurement of telomere length in appropriate cells of the patient prior to initiation of the telomerase inhibitor treatment.
Related Terms: Adverse Reaction Cells Erase Inhibitor Telomerase Telomere